Angiodynamics (ANGO) Total Liabilities (2011 - 2026)

Angiodynamics' Total Liabilities history runs 16 years deep, the most recent figure standing at $96.3 million for Q2 2026.

• Quarterly Total Liabilities fell 0.86% year-over-year to $96.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $96.3 million (down 0.86% YoY) and the FY2026 annual result came in at $96.3 million, down 0.86% from the prior year.
• Total Liabilities was $96.3 million for Q2 2026 at Angiodynamics, up from $87.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $154.3 million in Q2 2023 and bottomed at $66.1 million in Q3 2023.
• A 5-year average of $110.0 million and a median of $102.2 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities slumped 53.94% — and 2024, when it surged 46.72%.
• Angiodynamics' Total Liabilities stood at $150.2 million in 2022, then slumped by 34.51% to $98.4 million in 2023, then increased by 6.49% to $104.8 million in 2024, then slipped by 10.91% to $93.3 million in 2025, then climbed by 3.2% to $96.3 million in 2026.
• Business Quant data shows ANGO's Total Liabilities at $96.3 million in Q2 2026, $87.3 million in Q1 2026, and $93.3 million in Q4 2025.